• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Detection of translocation using dual color FISH probes in T-cell acute lymphoblastic leukemia-an illustrative report and review of literature.

作者信息

Virk Harpreet, Sreedharanunni Sreejesh, Palla Swetha, Rastogi Pulkit, Rathore Shailja, Anshu Anshu, Trehan Amita

机构信息

Department of Hematology, Advanced Paediatric Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Unit of Paediatric Haemato-Oncology, Department of Paediatrics, Advanced Paediatric Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

出版信息

Blood Res. 2022 Dec 31;57(4):278-281. doi: 10.5045/br.2022.2022134. Epub 2022 Nov 9.

DOI:10.5045/br.2022.2022134
PMID:36348635
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9812733/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6df6/9812733/5623ae48087b/br-57-4-278-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6df6/9812733/5623ae48087b/br-57-4-278-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6df6/9812733/5623ae48087b/br-57-4-278-f1.jpg

相似文献

1
Detection of translocation using dual color FISH probes in T-cell acute lymphoblastic leukemia-an illustrative report and review of literature.使用双色荧光原位杂交探针检测T细胞急性淋巴细胞白血病中的易位——一份实例报告及文献综述
Blood Res. 2022 Dec 31;57(4):278-281. doi: 10.5045/br.2022.2022134. Epub 2022 Nov 9.
2
NUP214-ABL1-mediated cell proliferation in T-cell acute lymphoblastic leukemia is dependent on the LCK kinase and various interacting proteins.NUP214-ABL1 介导的 T 细胞急性淋巴细胞白血病中的细胞增殖依赖于 LCK 激酶和各种相互作用的蛋白。
Haematologica. 2014 Jan;99(1):85-93. doi: 10.3324/haematol.2013.088674. Epub 2013 Jul 19.
3
Unique amplification of BCR-ABL1 gene fusion in a case of T-cell acute lymphoblastic leukemia.1例T细胞急性淋巴细胞白血病中BCR-ABL1基因融合的独特扩增
Mol Cytogenet. 2017 Oct 26;10:39. doi: 10.1186/s13039-017-0340-6. eCollection 2017.
4
Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia.靶向PI3K/AKT/mTOR通路或NUP214-ABL1融合蛋白的选择性抑制剂在人类急性淋巴细胞白血病中的协同作用
Oncotarget. 2016 Nov 29;7(48):79842-79853. doi: 10.18632/oncotarget.13035.
5
Case Report: Specific ABL-Inhibitor Imatinib Is an Effective Targeted Agent as the First Line Therapy to Treat B-Cell Acute Lymphoblastic Leukemia With a Cryptic :: Gene Fusion.病例报告：特定的 ABL 抑制剂伊马替尼是治疗伴有隐匿性::基因融合的 B 细胞急性淋巴细胞白血病的一线有效靶向药物。
Pathol Oncol Res. 2022 Sep 12;28:1610570. doi: 10.3389/pore.2022.1610570. eCollection 2022.
6
Detection of a cryptic gene fusion by mate-pair sequencing (MPseq) in a newly diagnosed case of pediatric T-lymphoblastic leukemia.在一例新诊断的儿童T淋巴细胞白血病病例中，通过配对末端测序（MPseq）检测到一个隐匿性基因融合。
Cold Spring Harb Mol Case Stud. 2019 Apr 1;5(2). doi: 10.1101/mcs.a003533. Print 2019 Apr.
7
[Variant Philadelphia chromosome identified by interphase fluorescence in situ hybridization (FISH) without evidence on G-banded karyotyping and metaphase FISH].通过间期荧光原位杂交（FISH）鉴定出的变异型费城染色体，在G带核型分析和中期FISH中无证据显示
Korean J Lab Med. 2010 Dec;30(6):711-7. doi: 10.3343/kjlm.2010.30.6.711.
8
Dasatinib and chemotherapy in a patient with early T-cell precursor acute lymphoblastic leukemia and fusion: A case report.达沙替尼与化疗用于一名伴有 融合的早期 T 细胞前体急性淋巴细胞白血病患者：病例报告
Exp Ther Med. 2017 Nov;14(5):3979-3984. doi: 10.3892/etm.2017.5046. Epub 2017 Aug 28.
9
Intrinsic differences between the catalytic properties of the oncogenic NUP214-ABL1 and BCR-ABL1 fusion protein kinases.致癌性NUP214-ABL1和BCR-ABL1融合蛋白激酶催化特性的内在差异。
Leukemia. 2008 Dec;22(12):2208-16. doi: 10.1038/leu.2008.242. Epub 2008 Sep 11.
10
Chemotherapy Resistance in B-ALL with Cryptic NUP214-ABL1 Is Amenable to Kinase Inhibition and Immunotherapy.隐匿性 NUP214-ABL1 导致的 B-ALL 对化疗耐药，可通过激酶抑制和免疫治疗克服。
Oncologist. 2022 Mar 4;27(2):82-86. doi: 10.1093/oncolo/oyab052.

引用本文的文献

1
Effective Utilization of a Customized Targeted Hybrid Capture RNA Sequencing in the Routine Molecular Categorization of Adolescent and Adult B-Lineage Acute Lymphoblastic Leukemia: A Real-World Experience.定制靶向杂交捕获RNA测序在青少年和成人B淋巴细胞系急性淋巴细胞白血病常规分子分类中的有效应用：一项真实世界经验
Mol Diagn Ther. 2025 May;29(3):407-418. doi: 10.1007/s40291-025-00779-5. Epub 2025 Apr 5.
2
Genomic technologies for detecting structural variations in hematologic malignancies.用于检测血液系统恶性肿瘤结构变异的基因组技术
Blood Res. 2024 Feb 13;59(1):1. doi: 10.1007/s44313-024-00001-1.

本文引用的文献

1
Case Report: A Case With Philadelphia Chromosome Positive T-Cell Lymphoblastic Lymphoma and a Review of Literature.病例报告：一例费城染色体阳性的T细胞淋巴母细胞淋巴瘤病例及文献综述
Front Oncol. 2021 Jan 20;10:584149. doi: 10.3389/fonc.2020.584149. eCollection 2020.
2
An Evaluation of a Fluorescence In Situ Hybridization Strategy Using Air-dried Blood and Bone-marrow Smears in the Risk Stratification of Pediatric B-Lineage Acute Lymphoblastic Leukemia in Resource-limited Settings.在资源有限的环境中，利用空气干燥血和骨髓涂片的荧光原位杂交策略评估儿科 B 系急性淋巴细胞白血病的风险分层。
J Pediatr Hematol Oncol. 2021 May 1;43(4):e481-e485. doi: 10.1097/MPH.0000000000001892.
3
JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors.
T 细胞急性淋巴细胞白血病中的 JAK/STAT 信号通路突变，包括 STAT5B N642H 突变，对 JAK1/JAK3 抑制剂敏感。
Hemasphere. 2019 Oct 22;3(6):e313. doi: 10.1097/HS9.0000000000000313. eCollection 2019 Dec.
4
Evidence for BCR/ABL1-positive T-cell acute lymphoblastic leukemia arising in an early lymphoid progenitor cell.证据表明，BCR/ABL1 阳性 T 细胞急性淋巴细胞白血病起源于早期淋巴祖细胞。
Pediatr Blood Cancer. 2019 Sep;66(9):e27829. doi: 10.1002/pbc.27829. Epub 2019 May 28.
5
Detection of a cryptic gene fusion by mate-pair sequencing (MPseq) in a newly diagnosed case of pediatric T-lymphoblastic leukemia.在一例新诊断的儿童T淋巴细胞白血病病例中，通过配对末端测序（MPseq）检测到一个隐匿性基因融合。
Cold Spring Harb Mol Case Stud. 2019 Apr 1;5(2). doi: 10.1101/mcs.a003533. Print 2019 Apr.
6
Dasatinib and chemotherapy in a patient with early T-cell precursor acute lymphoblastic leukemia and fusion: A case report.达沙替尼与化疗用于一名伴有 融合的早期 T 细胞前体急性淋巴细胞白血病患者：病例报告
Exp Ther Med. 2017 Nov;14(5):3979-3984. doi: 10.3892/etm.2017.5046. Epub 2017 Aug 28.
7
Clinical characteristics of Philadelphia positive T-cell lymphoid leukemias-(De novo and blast phase CML).费城染色体阳性T细胞淋巴白血病的临床特征 - （初发及急变期慢性粒细胞白血病）
Am J Hematol. 2017 Jan;92(1):E3-E4. doi: 10.1002/ajh.24579. Epub 2016 Nov 18.
8
Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia.一名NUP214-ABL1阳性T细胞急性淋巴细胞白血病患者接受达沙替尼一线单药治疗后迅速完全细胞遗传学缓解。
Leukemia. 2009 Mar;23(3):627-9. doi: 10.1038/leu.2008.318. Epub 2008 Nov 6.
9
Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia.T细胞急性淋巴细胞白血病中NUP214-ABL1融合基因的异质性扩增模式
Leukemia. 2009 Jan;23(1):125-33. doi: 10.1038/leu.2008.278. Epub 2008 Oct 16.
10
Transition from EML1-ABL1 to NUP214-ABL1 positivity in a patient with acute T-lymphoblastic leukemia.一名急性T淋巴细胞白血病患者从EML1-ABL1阳性转变为NUP214-ABL1阳性。
Leukemia. 2006 Dec;20(12):2202-4. doi: 10.1038/sj.leu.2404425. Epub 2006 Oct 5.